Dario Livio Longo Selected Research

Gd-AAZTA-MADEC

1/2021	Investigating plasma volume expanders as novel macromolecular MRI-CEST contrast agents for tumor contrast-enhanced imaging.
1/2016	Gd-AAZTA-MADEC, an improved blood pool agent for DCE-MRI studies on mice on 1 T scanners.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dario Livio Longo Research Topics

Disease

29	Neoplasms (Cancer) 02/2024 - 09/2013
7	Acidosis 01/2023 - 01/2020
3	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024 - 01/2018
3	Breast Neoplasms (Breast Cancer) 11/2023 - 03/2016
3	Triple Negative Breast Neoplasms 11/2023 - 01/2022
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 02/2024 - 08/2023
2	Prostatic Neoplasms (Prostate Cancer) 12/2022 - 10/2022
2	Melanoma (Melanoma, Malignant) 12/2021 - 06/2017
2	Osteosarcoma (Osteogenic Sarcoma) 11/2021 - 01/2021
1	Hypoxia (Hypoxemia) 12/2022
1	Body Weight (Weight, Body) 10/2022
1	Neoplasm Metastasis (Metastasis) 11/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Ischemia 01/2021
1	Kidney Diseases (Kidney Disease) 01/2021
1	Adenocarcinoma 01/2021
1	Adenocarcinoma of Lung 04/2020
1	Atrophy 01/2018
1	Cachexia 01/2018
1	Reperfusion Injury 07/2017
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 07/2017
1	Hyperplasia 01/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2015
1	Infections 09/2013
1	Carcinoma (Carcinomatosis) 09/2013
1	Acute Kidney Injury (Acute Renal Failure) 09/2013
1	Rhabdomyolysis 09/2013

Drug/Important Bio-Agent (IBA)

10	Contrast MediaIBA 01/2023 - 09/2013
9	Iopamidol (Isovue)FDA LinkGeneric 01/2023 - 09/2013
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
4	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 01/2019
3	cariporideIBA 11/2023 - 10/2022
3	AcidsIBA 11/2023 - 01/2021
3	Adenosine Triphosphatases (ATPase)IBA 11/2023 - 10/2022
3	Amiloride (Midamor)FDA LinkGeneric 11/2023 - 10/2022
3	Proton Pump InhibitorsIBA 11/2023 - 10/2022
3	Esomeprazole (Nexium)FDA Link 11/2023 - 10/2022
3	Lansoprazole (Prevacid)FDA LinkGeneric 11/2023 - 10/2022
2	Immunoconjugates (Immunoconjugate)IBA 02/2024 - 08/2023
2	UreaseIBA 02/2024 - 08/2023
2	Urea (Carbamide)FDA LinkGeneric 02/2024 - 08/2023
2	Membrane Proteins (Integral Membrane Proteins)IBA 02/2024 - 08/2023
2	Protons (Proton)IBA 11/2023 - 12/2022
2	Bicarbonates (Hydrogen Carbonate)IBA 09/2023 - 01/2023
2	Gd-AAZTA-MADECIBA 01/2021 - 01/2016
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2020 - 08/2017
2	VaccinesIBA 12/2015 - 07/2015
1	SolutionsIBA 09/2023
1	Liposomes (Liposome)IBA 09/2023
1	BuffersIBA 09/2023
1	AndrogensIBA 12/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	3-O-Methylglucose (3 O Methylglucose)IBA 12/2021
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2021
1	Interleukin-6 (Interleukin 6)IBA 11/2021
1	Serine (L-Serine)FDA Link 01/2021
1	LipidsIBA 01/2021
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2021
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2021
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2021
1	HES 130-0.4IBA 01/2021
1	GadoliniumIBA 01/2021
1	Plasma SubstitutesIBA 01/2021
1	Dextrans (Dextran)FDA Link 01/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 04/2020
1	DNA (Deoxyribonucleic Acid)IBA 04/2020
1	Oxygen (Dioxygen)IBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	Conditioned Culture MediaIBA 01/2018
1	Explosive Agents (Explosives)IBA 01/2018
1	Imatinib Mesylate (Gleevec)FDA Link 07/2017
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 06/2017
1	Meglumine FDA Link 06/2017
1	Excipients (Suspending Agents)IBA 06/2017
1	Pyrrolidinones (Pyrrolidones)IBA 06/2017
1	Sucrose (Saccharose)IBA 06/2017
1	AcetylglucosamineIBA 06/2017
1	ioversol FDA Link 03/2016
1	Iohexol (Omnipaque)FDA Link 03/2016
1	Deoxycholic Acid (Sodium Deoxycholate)IBA 01/2016
1	AlbuminsIBA 01/2016
1	gadofosveset trisodium (MS 325)FDA Link 01/2016
1	SuspensionsIBA 12/2015
1	Cancer VaccinesIBA 12/2015
1	Tyrosine Kinase InhibitorsIBA 12/2015
1	Anaplastic Lymphoma KinaseIBA 12/2015
1	A-Form DNA (A-DNA)IBA 07/2015
1	Complement C3 (C3 Complement)IBA 09/2013
1	Glycerol (Glycerine)FDA LinkGeneric 09/2013
1	Complement System Proteins (Complement)IBA 09/2013

Therapy/Procedure

5	Therapeutics 01/2023 - 07/2015
3	Drug Therapy (Chemotherapy) 01/2023 - 01/2021
2	Immunotherapy 02/2024 - 08/2023
1	Injections 01/2023
1	Intravenous Administration 12/2021
1	Intravenous Injections 03/2016